200: What They Don’t Tell You About Drug Safety — And Why God Must Come First in Your Health
If you have ever felt uneasy about a prescription but could not quite explain why, this episode is for you. Not because the goal is to scare you, but because you deserve to understand how the system actually works — from someone who worked inside it for years.
Welcome
I am a Registered Nurse and Christian holistic health coach, and before I ever coached women toward natural healing, I spent years inside the pharmaceutical industry working in drug safety and pharmacovigilance. I processed the reports. I saw the conflicts of interest. And eventually, I became the patient.
This episode is for the Christian woman who has been dismissed, medicated, and sent home with a prescription and zero real answers. The woman who suspects there is a better way but does not know where to start. If that is you, keep listening.
What the Drug Approval Process Actually Looks Like
Most people assume that by the time a drug reaches your pharmacist, it has been tested on hundreds of thousands of people over decades. The reality is more sobering.
Before a drug is approved, it goes through clinical trials. For your average drug, the median total number of participants across all clinical trials before FDA approval is 1,708 people. For orphan drugs — drugs created for rare diseases — that number drops to a median of 438 participants.
That is the data your doctor’s prescription is based on.
The Conflict of Interest Nobody Talks About
Here is what most people outside the industry do not know. When a patient has an adverse event during a clinical trial, a report gets sent to the drug safety department. A physician is then required to determine whether or not the drug caused that event.
But that physician works for — or is contracted by — the pharmaceutical company.
The chief medical officer, the person setting the tone for how reports are assessed, has a financial stake in the outcome. Even the most ethical physician in that position faces a fundamental conflict of interest. And in some cases, if the clinical trial investigator — the doctor actually watching the patient — determines the drug caused the adverse event, the pharmaceutical company’s physician can override that assessment entirely.
The Human Factor Inside the System
The people who work in drug safety are largely detail-oriented, hardworking, and genuinely care about patient outcomes. That matters and it is worth saying.
But the system itself has real limitations.
High turnover rates mean institutional knowledge walks out the door constantly. Clinical trial teams spread across the globe sometimes do not understand their own reporting obligations. Physicians reviewing dozens of nearly identical reports daily are fighting boredom and burnout. And patients taking 10, 15, or even 30 medications at once make causality nearly impossible to determine with any real certainty.
The science is not as clean as the packaging suggests.
After FDA Approval — The Data Gets Even Thinner
Once a drug is on the market, the primary way a pharmaceutical company learns about safety issues is through voluntary reports — from you or your doctor. Most patients have never heard of a pharmacovigilance department. Most healthcare professionals do not know they can or should be reporting adverse events directly to pharmaceutical companies.
That means the post-market safety data is largely dependent on a system most people do not know exists.
Vioxx is the example that opened this episode. FDA approved. Widely prescribed. Pulled from the market after data showed an increased risk of heart attacks and strokes. The clinical trials passed. The stamp of approval was given. And people were still harmed.
What This Means for Your Health Decisions
None of this means every pharmaceutical product is dangerous or that every person working in the industry has bad intentions. That is not the point.
The point is discernment.
The safety profile of the drug you may be taking rests heavily on the worldview of one chief medical officer at one pharmaceutical company, filtered through a reporting system most people have never heard of, built on a data set far smaller than most people realize.
That is not a conspiracy. That is just how the system is structured.
Why God Must Come First
My friend had Crohn’s disease for roughly 15 years. One day she was healed. Her doctor’s response? It must be that you never had Crohn’s disease in the first place.
That response reveals everything about a worldview that cannot make room for healing outside of its own framework.
God is not limited by what the data set allows. He is not constrained by what the chief medical officer approves. His wisdom is complete, and He designed your body with purpose and precision.
I am not here to get you off your medications. I am not here to tell you pharmaceutical companies are entirely bad. My mission is simpler and more important than that — to encourage you to go to God first. To seek His wisdom before you outsource your health to a system that was never designed to heal you.
As one of my dear friends shared with me for my book, Discover God’s Health Wisdom:
Science and knowledge are gifts from the Almighty One, yet they are not God. When we believe the deception that academia, research, and humanity’s partial understanding is more powerful than the One who created it all, then it controls us and leaves us susceptible to more deception.
Time-Stamped Highlights
0:01 — The Vioxx story: what it reveals about FDA approval and drug safety
1:00 — What pharmacovigilance is and why most people have never heard of it
3:51 — The good inside the system: the people who genuinely care
4:17 — The chaotic human factor and the God complex in conventional medicine
7:08 — The conflict of interest at the heart of drug safety assessments
9:29 — The clinical trial data sets: how many people a drug is actually tested on
11:22 — Post-market reporting and why the data gets thinner after approval
13:15 — Why comorbidities and polypharmacy make causality nearly impossible to assess
16:31 — How a physician’s worldview shapes the safety conclusions of an entire drug program
17:56 — The invitation: go to God first for your health
Key Takeaways
- Drug approvals are based on smaller data sets than most people assume — medians of 1,708 participants for standard drugs and 438 for orphan drugs across all clinical trials
- The physician determining whether a drug caused an adverse event often works directly for the pharmaceutical company — a structural conflict of interest
- Post-market safety data depends largely on voluntary reporting from patients and doctors, most of whom do not know the system exists
- The science is real and has genuine value — but it is incomplete, human, and subject to bias like every other human system
- Seeking God’s wisdom first does not mean rejecting medicine; it means approaching your health with discernment rather than blind trust
- True lasting healing is possible — and God’s design for your body is more complete than any clinical trial
Ready to Stop Outsourcing Your Health?
If this episode stirred something in you — if you have been wondering whether there is a better path forward for your energy, your autoimmune symptoms, or your overall health — I want to invite you to book a More Energy Strategy Session with me.
This is a private, one-on-one conversation where we look at what is actually going on in your body and begin building a path forward rooted in God’s design for your health. Not another prescription. Not another dead end.
If you are ready to stop spinning your wheels and start moving forward with clarity and confidence, the link is herholistichealing.com/services.